InvestorsHub Logo
Followers 65
Posts 23724
Boards Moderated 0
Alias Born 11/23/2016

Re: georgejjl post# 364522

Sunday, 06/26/2022 3:56:26 PM

Sunday, June 26, 2022 3:56:26 PM

Post# of 457672
That is yet another unsupported claim!

The target dose for those ca. 132 patients is 50mg, but we don't know what dose level each patient actually achieves. It seems pretty certain that all ca. 132 will not achieve 50mg.

With approximately 132 trial participants taking 50 mg of Blarcamesine per day, the results shall be clearly spectacular.


As to how spectacular the results will be only time will tell. Hopefully clearly and undeniably better than SOC,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News